UNIT 2 (DRUG PRODUCT STABILITYㅡPACKAGING & LABELLING) Flashcards

1
Q
  • extent a product retains, within specified limits, and through its period of storage and use the same properties and characteristics that it possessed at the time of its manufacture
A

STABILITY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  • drug molecules interact with water molecule to yield breakdown product.
  • susceptible to the hydrolytic process: esters, substituted amides, lactones, and lactams
A

Hydrolysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  • this drug undergo hydrolysis. It combines with water molecules and hydrolysis into one molecule of salicylic acid and one molecule of acetic acid.
A

ASPIRIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  • loss of electrons from an atom or molecule;
  • In organic chemistry, oxidation is defined as the loss of hydrogen in molecule. Meanwhile, in inorganic chemistry, oxidation is defined as the increase in the positive valence of an element.
  • Involves free radicals (molecules or atoms containing one or more unpaired electrons). These radicals tend to take electrons from other chemicals, thereby oxidizing the donor.
A

OXIDATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  • Many oxidative changes in pharmaceutical preparation have the character of autoxidation.
  • occur spontaneously under the initial influence of atmospheric oxygen and proceed slowly at first and then more rapidly
  • As pharmacist in the industry like manufacturing and formulation, keeping an eye on these processes is important.
  • The process has been described as a type of chain reaction commencing with the union of oxygen with the drug molecule and continuing with a free radical of this oxidized molecule participating in the destruction of other drug molecules and so forth.
A

Autoxidation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Five types of Stability

A

Chemical
Physical
Microbiologic
Therapeutic
Toxicologic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  • the study of the rate of chemical change and the way this rate is influenced by concentration of reactants, products, and other chemical species and by factors such as solvent, pressure, and temperature.
A

Reaction kinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

● description of the drug concentration with respect to time.

A

Reaction rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

be the overall order (the sum of the exponents of the concentration terms of the rate expression) or the order with respect to each reactant (the exponent of the individual concentration term in the rate expression).

A

Reaction order

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  • estimate the shelf life of a product that has been stored or to be stored under a different set of conditions.
  • In other words, it is useful for estimating the shelf life at room temperature of product recommended for cold storing. So it is one way to determine the stability of the drug product.
A

Q10 METHOD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

waterproof protective coating applied in the tablet or keeping in tightly closed container

A

water-labile drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

o is adding a specified volume of purified water before we dispense.

The reason of this since the drug degrade easily on water. So the moment we reconstitute, the drug’s shelf life also lessen. Therefore, it is imperative as pharmacist to inform the patients to store suspensions on refrigerator

A

Reconstitute

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

● For unstable preps: storage under refrigeration optimum stability:

A

pH 5 ㅡ 6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

● Oxygen sensitive drugs add antioxidants:

A

o in aqueous preparations:

▪ Na2SO3 | NaHSO3 | Na2S2O5 | H3PO2 | ascorbic acid

o in oleaginous/ unctuous preparations:

▪ alphatocopherol, butylhydroxyanisole & ascorbyl palmitate find application

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  • Constant source of difficulty in preparing stable solutions of oxidizable drugs
A

● Trace metals form drug, solvent, container or stopper

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

● Trace metals form drug, solvent, container or stopper is eliminated by:

A

○ purification of source of contaminant

○ chemically complexing or binding metal by using specialized agents make it chemically unavailable for participation in the oxidative process. (chelating agents- Ca Disodium edetate & EDTA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q
  • catalyst to oxidation reactions transferring its energy (photons) to drug molecules, making the latter more reactive through increased energy capability
A

Light

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

IN SUMMARY, EASILY OXIDIZABLE DRUGS MAY BE STABILIZED IN FORMULATION BY:

A

● Selective exclusion from the system of:

o Oxygen, oxidizing agents, trace metals, light, heat, other chemical catalysts to oxidation.

● Add to create and maintain a favorable pH:

o Antioxidants, chelating agents, buffering agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

reaction between two or more identical molecules with resultant formation of new & generally larger molecule (formaldehyde)

● Process where one or more active chemical groups removed:

o Chemical decarboxylation: decomposition of RCOOH & release of CO2

o Deamination: removal of nitrogen containing group from organic amine (ex. Insulin)

▪ These processes occur less frequently and is only peculiar or particular to only small groups of substances

A

Polymerization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

● Studies designed to increase the rate of chemical degradation or physical change of a drug substance or drug product by using exaggerated storage conditions as part of long-term, intermediate, and accelerated studies.

A

Accelerated testing

21
Q

The dosage form in the final immediate packaging intended for marketing.

A

Drug product

22
Q

● The unformulated drug substance that may subsequently be formulated with excipients to produce the dosage form.

A

Drug substance

23
Q

● Anything other than the drug substance in the dosage form.

A

Excipient

24
Q

● The date placed on the container label of a drug product designating the time prior to which a batch of the product is expected to remain within the approved shelf life specification, if stored under defined conditions, and after which it must not be used.

A

Expiration date

25
Q

● The time period during which a drug product is expected to remain within the approved shelf life specification, provided that it is stored under the conditions defined on the container label.

A

Shelf life (also referred to as expiration dating period)

26
Q

● Studies undertaken to elucidate the intrinsic stability of a drug substance. Such testing is part of the drug development process and is normally carried out under more severe conditions than those used for accelerated testing.

A

Stress testing (drug substance)

27
Q

● Studies undertaken to assess the effect of severe conditions on the drug product. Such studies include photo stability testing as well as the specific testing of certain product types (e.g., metered dose inhalers, creams, emulsions).

A

Stress testing (drug product)

28
Q

● Four climatic zones can be distinguished for the purpose of worldwide stability testing, as follows:

A

✔ Zone I: temperate

✔ Zone II: subtropical with possible high humidity

✔ Zone III: hot/dry

✔ Zone IV: hot/humid

29
Q

another term for drug product

A

ARTICLE

30
Q
  • protects the contents from extraneous solids and from loss of the article under ordinary conditions of handling, shipment, storage & distribution
A

➔ WELL-CLOSED CONTAINER

31
Q
  • protects the contents from contamination by extraneous liquids solids, or vapors, from loss of the articles, and from efflorescence, deliquescence, or evaporation under the ordinary or customary conditions of handling, shipment, storage and distribution and is capable of tight re-closure
A

➔ TIGHT CONTAINER

32
Q
  • Impervious/resistant to air or any other gas under the ordinary or customary conditions of handling, shipment, storage, and distribution
  • Ex. Teflon - polytetrafluoroethylene, a material used in seal out hermetic container.
A

➔ HERMETIC CONTAINER

32
Q
  • one that holds a quantity of drug intended as a single dose and, when opened, cannot be resealed with assurance that sterility has been maintained
  • Ex.
  • Ampule - you open this container by tearing the cap. So once it was teared, it could no longer be sealed back
  • single dose syringes like clexane - an anticoagulant drug use to treat a type of blood cloth, the deep vein thrombosis.
  • solo Medrol vial - its container known as ACT -O vial. This is a dual components vial system that allows reconstitution of sterile injectable medication by pressing on the cap. Interestingly, the container is divided by rubber stopper where the upper part contains water and the lower part contains the powder.
A

➔ SINGLE-DOSE CONTAINER

33
Q
  • hermetic container that permits withdrawal of successive portions of the contents without changing the strength or endangering the quality or purity of the remaining portion.
  • referred as vials
  • contain more than a single unit or dose of the medication
  • Ex. Amber glass, diazepam vial, ( for anxiety) insulin pens ( for diabetes).
A

➔ MULTIPLE-DOSE CONTAINER

34
Q
  • designed to hold a quantity of drug intended for administration as a single dose promptly after the container is opened
  • Advantages

o positive identification of each dosage unit and reduction of medication errors

o reduced contamination of the drug due to its protective wrapping

o reduced dispensing time

A

➔ SINGLE UNIT PACKAGES

35
Q
  • required by many pharmaceutical products to protect them from photochem. deterioration

▪ Meaning to say these products are sensitive to light or will degrade if they will be directly exposed to light.

  • amber glass or light resistant opaque plastic will reduce light transmission sufficiently to protect a light-sensitive pharmaceutical
  • UV absorbers may be added to plastic to decrease the transmission of short UV rays
A

➔ LIGHT RESISTANT CONTAINERS

36
Q

CLASSIFICATION OF GLASS USED IN PACKAGING PHARMACEUTICALS: depending upon the chemical constitution of the glass and its ability to resist deterioration:

A

I

Highly resistant borosilicate glass

II

Treated soda lime glass

III

Soda lime glass

NP

General purpose soda lime glass

37
Q
  • Low Density PE: squeezable

▪ eye drops, medicine dropper, spray bottles

  • High Density PE: hard-thermoset

▪ Solid dosage forms

A

Polyethylene

38
Q
  • For beverages
A

Polyethylene Terephthalate

39
Q
  • Made by addition of chlorine atom to every other carbon atom in the polymer chains of polyethylene.
  • Characteristics: resistant to permeation, it is rigid, it has good clarity however it is not suitable for gamma sterilization.
  • Blister Packaging of tablets and capsules.
A

Polyvinyl Chloride

40
Q

PROBLEMS ENCOUNTERED IN THE USE OF PLASTICS IN PACKAGING

A

➔ Permeability of the containers to atmospheric oxygen and to moisture vapor

➔ Leaching of the constituents of the container to the internal contents

➔ Absorption of drugs from the contents to the container

➔ Transmission of light through the container alteration of the container upon storage

41
Q

● considered a process of solution and diffusion, with the penetrant dissolving in the plastic on one side and diffusing through to the other side.

A

PERMEABILITY

42
Q

● movement of components of a container into the contents

● Compounds leached from the plastic containers are polymer additives as the plasticizers, stabilizers or antioxidants

A

LEACHING

43
Q

• binding of molecules to polymer materials

• absorption and adsorption are considered as a single process

A

Sorption

44
Q

o this is a process in which a fluid is dissolved by a liquid or a solid.

A

Absorption

45
Q

this is a process in which atoms or molecules from a substance adhere to the surface of adsorbents

A

Adsorption

46
Q

defined as:

o significantly difficult for children under 5 years of age to open or to obtain a harmful amount of its contents within a reasonable time

o not difficult for “normal adults” to use properly.

A

• Child-resistant container

47
Q

TERMS EMPLOYED FOR THE DESIRED CONDITIONS AS DEFINED BY THE USP:

A

• Cold

  • any temp not exceeding 8°C (46˚F)
  • a refrigerator is a cold place where the temp. is maintained bet. 2 °C and 8°C (36° and 46°F)

• Cool

  • any temp bet. 8 ° and 15 ° C (46˚ and 59˚F)

• Room Temp.

  • temp prevailing in a working area
  • 20˚ to 25˚C (68˚F to 77˚F) but also allows for temp variations bet 15˚ and 30˚C (59˚ and 86˚F) experienced in pharmacies, hospitals, and drug warehouses

• Warm

  • any temp bet 30˚ and 40˚C (86˚F)

• Excessive Heat λ

  • any temp above 40˚C (104˚F)
48
Q

SIGNS OF DEGRADATION OF THE SPECIFIC DOSAGE FORMS MUST BE OBSERVED AND REPORTED:

A

• Tablets: Appearance (cracking, chipping, mottling), friability, hardness, color.

• Capsules: Moisture tackiness, color appearance, shape, brittleness and dissolution

o Moisture tackiness - when hard capsule gel turns to soft gel.

• Oral Solutions and Suspensions: Appearance, precipitation, pH, color, odor, dispersibility (suspension) and clarity (solutions)

• Oral Powders: Appearance, color, odor, moisture

• Metered–dose inhalation aerosols delivered dose per activation, number of metered doses, color, particle size distribution, loss of propellant, pressure, valve corrosion, spray pattern, absence of pathogenic microorganism

• Topical creams: ointments, lotions, solutions, and gels. Appearance, color, homogeneity, odor, pH, resuspendability (lotions), consistency, particle size, distribution strength, weight loss.

• Ophthalmic and Nasal and Oral inhalation preparations: Appearance, color consistency, pH, clarity (solutions), particle size, and resuspendability (suspensions, ointments), strength and sterility.

• Small Volume Parenterals: Appearance, color, clarity, particulate matter, pH volumes and extractable (when plastic containers are used), sterility, pyrogenicity and closure integrity.

• Suppositories: Softening range; appearance and melting.

• Emulsions: Appearance (such as phase separation) color, odor, pH, and viscosity.

• Controlled release membrane drug delivery systems: seal strength of the drug reservoir, decomposition products, membrane integrity, drug strength and drug release rate.